Similar articles

• A case of rapid avacopan-induced liver injury in pediatric granulomatosis with polyangiitis.

  Nishino T, Tomori S, Haruyama M, Takahashi K, Mimaki M. Nishino T, et al. Pediatr Nephrol. 2024 Oct;39(10):2919-2922. doi: 10.1007/s00467-024-06376-8. Epub 2024 Apr 15. Pediatr Nephrol. 2024. PMID: 38619581
• Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis.

  Harigai M, Takada H. Harigai M, et al. Mod Rheumatol. 2022 Apr 18;32(3):475-483. doi: 10.1093/mr/roab104. Mod Rheumatol. 2022. PMID: 34984461
• Improved Hearing Impairment of Granulomatosis with Polyangiitis Treated with Rituximab and Avacopan without Glucocorticoids.

  Okubo A, Fukui S, Tanigawa M, Kojima K, Sumiyoshi R, Koga T, Shojinaga S, Sakamoto R, Nakashima M, Kawakami A. Okubo A, et al. Intern Med. 2024 Sep 1;63(17):2455-2460. doi: 10.2169/internalmedicine.3072-23. Epub 2024 Feb 5. Intern Med. 2024. PMID: 38311424 Free PMC article.
• [Update on treatment of ANCA-associated vasculitis: Granulomatosis with polyangiitis and Microscopic Polyangiitis].

  Holle JU, Hellmich B, Moosig F. Holle JU, et al. Z Rheumatol. 2022 May;81(4):280-285. doi: 10.1007/s00393-021-01154-5. Epub 2022 Jan 21. Z Rheumatol. 2022. PMID: 35061059 Review. German.
• Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab.

  Geetha D, Kallenberg C, Stone JH, Salama AD, Appel GB, Duna G, Brunetta P, Jayne D. Geetha D, et al. J Nephrol. 2015 Feb;28(1):17-27. doi: 10.1007/s40620-014-0135-3. Epub 2014 Sep 4. J Nephrol. 2015. PMID: 25185728 Free PMC article. Review.